A CDMO plays a crucial role in the pharmaceutical and biotechnology industries by providing comprehensive drug development ...

CD19-targeted therapy Breyanzi (lisocabtagene maraleucel) can now be used to treat adults with MZL – a rare and form of ...

The verdict is the latest twist in patent litigation between MSD and Halozyme, in which the latter is claiming that Keytruda ...

Despite their readiness, blood centres remain an underutilised lever in pharma’s innovation model. As industry players seek ...

Seven digital health technologies (DHTs) that can be used to support people recovering from cardiovascular diseases have been ...

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a ...

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

A survey of frontline NHS workers has found that almost two-thirds (61%) feel they are unprepared for the digital ...

Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or ...

From antibody–drug conjugates (ADCs) moving into early-stage disease to arenavirus-based immunotherapies and ctDNA-guided ...

In a recent blog post, the PhRMA industry organisation said that the PDUFA system is "essential to America's edge in drug ...

For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug ...